12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lymphoseek tilmanocept regulatory update

Navidea said FDA accepted for review the resubmission of an NDA for Lymphoseek tilmanocept for use in intraoperative lymphatic imaging. The agency designated the resubmission as a...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >